-- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
Securities code: 603367 Securities abbreviation: Chenxin Pharmaceutical Announcement number: 2025-048
Chenxin Pharmaceutical Co., Ltd.
Indicative announcement regarding changes in equity of shareholders holding more than 5% of shares touching the 1% mark
Han Yanzhen, a shareholder holding more than 5% of the shares, and Nanjing Chenxin Tongtai Venture Capital Co., Ltd., a person acting in concert, guarantee that the information provided to the company is true, accurate and complete, and contains no false records, misleading statements or major omissions. The company's board of directors and all directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Important content reminder:
Direction of change in equity: Increase in proportion□ Decrease in proportion√
Total ratio before changes in equity 7.36%
Total ratio after changes in equity 6.37%
Does this change violate the promise made?
Yes□ No√
promise, intention, plan
Whether the mandatory tender offer obligation is triggered? Yes□ No√
1. Basic information of information disclosure obligors and persons acting in concert
- Identity Category
□Controlling shareholder/actual controller and persons acting in concert
√Other major shareholders with more than 5% and their persons acting in concert
Identity of investors and their persons acting in concert: The largest shareholder and its persons acting in concert (only applicable to those without controlling shareholders or actual controllers)
□Other______________ (please specify)
- Information of information disclosure obligor
Name of information disclosure obligor Identity of investor Unified social credit code
□ Controlling shareholder/actual controller
□ Conformity of controlling shareholder/actual controller □ _____________
Han Yanzhen
Moving √ Not applicable
√ Other direct shareholders
- Information about persons acting in concert
Name of person acting in concert Investor identity Unified social credit code
□ Controlling shareholder/actual controller
Nanjing Chenxin Tongtai Venture Capital □ Consistent behavior of controlling shareholder/actual controller √ 91450500MAA7RJX51G Co., Ltd. Moving □ Not applicable
√ Other direct shareholders
2. Basic situation when equity changes touch the 1% mark
On August 29, 2025, the company received the "Share Reduction Situation" issued by Han Yanzhen, a shareholder holding more than 5% of the shares.
"Notification Letter", it was learned that on August 29, 2025, it reduced its holdings of the company's shares by 4.5% through centralized bidding transactions.
09,200 shares, accounting for 0.996% of the company's current total share capital.
After this equity change, Han Yanzhen and his concerted parties, Nanjing Chenxin Tongtai Venture Capital Co., Ltd.
The total number of company shares held decreased from 33,346,115 shares to 28,836,915 shares, and the total shareholding ratio increased from 7.
36% decreased to 6.37%, and the equity change touched the 1% mark.
Name of the investor who received the funds Number of shares before change Ratio before change Number of shares after change Ratio after change Change in equity Change in equity
Source (only added (10,000 shares) Example (%) (10,000 shares) Example (%) Method Time interval
Entities that directly change shareholdings:
Centralized bidding
√
Bulk transaction 2025/8/29-Han Yanzhen 3,197.7829 7.06 2,746.8629 6.07 -- □ 2025/8/29 Others:____
(please specify)
Entities that have not directly changed their shareholdings:
Nanjing Chenxin
Tongtai Entrepreneurship 136.8286 0.30
136.8286 0.30 // / Investment limited
company
3,334.6115 7.36 2,883.6915 6.37 -- -- --Total
3. Other instructions
This equity change is for Han Yanzhen, the company’s shareholder holding more than 5% of the company’s shares, to implement the previously disclosed shareholding reduction plan. For details, please refer to the “Announcement on the Shareholding Reduction Plan of Chenxin Pharmaceutical Co., Ltd. Shareholders Holding More than 5% of the Shares” disclosed by the company on the Shanghai Stock Exchange (www.sse.com.cn) on August 6, 2025 (Announcement Number: 2025-037). As of the disclosure date of this announcement, this shareholding reduction plan has not yet been completed.
This change in equity belongs to the reduction of shares held by shareholders holding more than 5% of the company's shares and does not involve a tender offer.
This change in equity will not have a significant impact on the company's governance structure and ongoing operations, nor will it cause changes in the company's controlling shareholders and actual controllers.
After this equity change, the company will continue to urge information disclosure obligors to strictly implement the relevant regulations on share reductions and disclose relevant information to investors in a timely manner. Investors are advised to pay attention to investment risks. Announcement is hereby made.
Board of Directors of Chenxin Pharmaceutical Co., Ltd.
September 1, 2025